Clinical Trial Update: Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis [NA]

View source ↗

Summary

This clinical trial compares nebulized 3% hypertonic saline to 0.9% saline in hospitalized patients with acute bronchiolitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Hypertonic saline 3% (nebulized) (Hypertonic saline 3%)
• Sodium chloride 0.9% (nebulized) (Normal saline 0.9%)

Snippet

Sponsor: Szpital im. Św. Jadwigi Śląskiej | Conditions: Bronchiolitis | NA | Status: COMPLETED